Chris Ambrose

2.4k total citations
13 papers, 138 citations indexed

About

Chris Ambrose is a scholar working on Physiology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chris Ambrose has authored 13 papers receiving a total of 138 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chris Ambrose's work include Asthma and respiratory diseases (9 papers), Pharmaceutical studies and practices (4 papers) and Respiratory and Cough-Related Research (3 papers). Chris Ambrose is often cited by papers focused on Asthma and respiratory diseases (9 papers), Pharmaceutical studies and practices (4 papers) and Respiratory and Cough-Related Research (3 papers). Chris Ambrose collaborates with scholars based in United States, United Kingdom and Finland. Chris Ambrose's co-authors include Phillip R. Bennett, Prabhakar Rajan, Vik Khullar, Anna C. Kirby, Rufus Cartwright, Marjo‐Riitta Järvelin, Andrew J. Walley, Altaf Mangera, Jori S. Pesonen and Tom Palmer and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, American Journal of Obstetrics and Gynecology and The Journal of Urology.

In The Last Decade

Chris Ambrose

12 papers receiving 134 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Ambrose United States 3 68 60 40 36 30 13 138
Cüneyt Günşar Türkiye 11 47 0.7× 180 3.0× 8 0.2× 84 2.3× 23 0.8× 36 257
Alexandra Rogers United States 6 56 0.8× 56 0.9× 4 0.1× 102 2.8× 29 1.0× 14 148
F. Dugardin France 7 57 0.8× 46 0.8× 10 0.3× 103 2.9× 130 4.3× 18 239
Lev Koltun Israel 7 68 1.0× 226 3.8× 7 0.2× 14 0.4× 18 0.6× 10 308
B D Gold United States 7 12 0.2× 104 1.7× 14 0.3× 19 0.5× 22 0.7× 17 192
Eric Ahnfeldt United States 7 45 0.7× 110 1.8× 15 0.4× 3 0.1× 19 0.6× 14 341
Joseph K. Izes United States 7 36 0.5× 130 2.2× 5 0.1× 47 1.3× 33 1.1× 14 201
Luigi G. Franciosi Canada 8 17 0.3× 64 1.1× 84 2.1× 24 0.7× 159 5.3× 10 271
Anup Vora United States 10 62 0.9× 71 1.2× 6 0.1× 83 2.3× 148 4.9× 13 214
Phillip M. Hanno United States 6 99 1.5× 93 1.6× 6 0.1× 248 6.9× 42 1.4× 8 333

Countries citing papers authored by Chris Ambrose

Since Specialization
Citations

This map shows the geographic impact of Chris Ambrose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Ambrose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Ambrose more than expected).

Fields of papers citing papers by Chris Ambrose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Ambrose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Ambrose. The network helps show where Chris Ambrose may publish in the future.

Co-authorship network of co-authors of Chris Ambrose

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Ambrose. A scholar is included among the top collaborators of Chris Ambrose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Ambrose. Chris Ambrose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Chipps, Bradley E., Njira Lugogo, Warner Carr, et al.. (2022). Clinical Remission with Biologic Use Among US Subspecialist-treated Patients with Severe Asthma: Results from the CHRONICLE Study. Journal of Allergy and Clinical Immunology. 149(2). AB147–AB147. 1 indexed citations
2.
Ambrose, Chris, Andrew Menzies‐Gow, Bill Cook, et al.. (2022). Efficacy of Tezepelumab in Patients with Moderate-to-Severe, Uncontrolled Asthma: A Pooled Analysis of the Phase 2b PATHWAY and Phase 3 NAVIGATOR Studies. Journal of Allergy and Clinical Immunology. 149(2). AB16–AB16. 1 indexed citations
3.
Carr, Tara F., Jonathan A. Bernstein, Bill Cook, et al.. (2022). Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with Respiratory Comorbidities: Results from the Phase 3 NAVIGATOR Study. Journal of Allergy and Clinical Immunology. 149(2). AB152–AB152. 2 indexed citations
4.
Griffiths, Janet M., Tuyet‐Hang Pham, Eileen Wang, et al.. (2022). Tezepelumab Reduces Inflammatory Biomarkers as Early as Week 2 and Maintains Reductions Until Week 52 in the Phase 3 NAVIGATOR Severe Asthma Trial. Journal of Allergy and Clinical Immunology. 149(2). AB14–AB14. 2 indexed citations
5.
Israel, Elliot, Andrew Menzies‐Gow, Geoffrey Chupp, et al.. (2021). Efficacy of tezepelumab in adolescents with severe, uncontrolled asthma. OA1490–OA1490. 1 indexed citations
6.
Tan, Laren, Joan Reibman, Chris Ambrose, et al.. (2021). Clinical and Economic Burden of Patients with Uncontrolled Severe Asthma with Low Blood Eosinophil Levels in the United States. Journal of Allergy and Clinical Immunology. 147(2). AB47–AB47. 1 indexed citations
7.
Reibman, Joan, Laren Tan, Chris Ambrose, et al.. (2021). Clinical and economic burden of severe asthma among US patients treated with biologic therapies. Annals of Allergy Asthma & Immunology. 127(3). 318–325.e2. 27 indexed citations
8.
Ambrose, Chris, Gene Colice, Kinga Sałapa, Jane R. Parnes, & Jonathan Corren. (2020). Effect of Tezepelumab on Exacerbations in Patients with Severe, Uncontrolled Asthma, According to Baseline Body Mass Index: Results from the Phase 2b PATHWAY Study. Journal of Allergy and Clinical Immunology. 145(2). AB25–AB25. 2 indexed citations
9.
Caspard, Hervé, Trung N. Tran, & Chris Ambrose. (2018). Population-based evaluation of blood eosinophil counts and association with patient characteristics in US adults with asthma. Journal of Allergy and Clinical Immunology. 141(2). AB103–AB103. 2 indexed citations
10.
Cartwright, Rufus, Anna C. Kirby, Kari A.O. Tikkinen, et al.. (2014). Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women. American Journal of Obstetrics and Gynecology. 212(2). 199.e1–199.e24. 74 indexed citations
11.
Cartwright, Rufus, Altaf Mangera, Kari A.O. Tikkinen, et al.. (2014). Systematic Review and Meta-analysis of Candidate Gene Association Studies of Lower Urinary Tract Symptoms in Men. European Urology. 66(4). 752–768. 22 indexed citations
12.
Kirby, Anna C., Rufus Cartwright, Kari A.O. Tikkinen, et al.. (2013). 116 CANDIDATE GENE ASSOCIATION STUDIES OF URINARY SYMPTOMS AND PELVIC ORGAN PROLAPSE IN WOMEN: A SYSTEMATIC REVIEW AND META-ANALYSIS. The Journal of Urology. 189(4S). 1 indexed citations
13.
Tikkinen, Kari A.O., Rufus Cartwright, Anna C. Kirby, et al.. (2013). 1733 CANDIDATE GENE ASSOCIATION STUDIES OF LOWER URINARY TRACT SYMPTOMS IN MEN: A SYSTEMATIC REVIEW AND META-ANALYSIS. The Journal of Urology. 189(4S). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026